HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
CTIC [NASD]
CTI BioPharma Corp.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.85 Insider Own0.20% Shs Outstand128.58M Perf Week-0.47%
Market Cap564.28M Forward P/E9.95 EPS next Y0.43 Insider Trans-76.39% Shs Float125.91M Perf Month-21.32%
Income-93.00M PEG- EPS next Q-0.10 Inst Own79.30% Short Float / Ratio12.69% / 5.29 Perf Quarter-22.74%
Sales53.90M P/S10.47 EPS this Y25.40% Inst Trans9.63% Short Interest15.97M Perf Half Y-27.70%
Book/sh-0.14 P/B- EPS next Y98.70% ROA-72.20% Target Price11.23 Perf Year-15.08%
Cash/sh0.61 P/C7.06 EPS next 5Y- ROE550.20% 52W Range3.32 - 7.80 Perf YTD-28.79%
Dividend- P/FCF- EPS past 5Y8.10% ROI-87.30% 52W High-45.13% Beta0.93
Dividend %- Quick Ratio1.20 Sales past 5Y16.50% Gross Margin93.50% 52W Low28.92% ATR0.22
Employees128 Current Ratio1.20 Sales Q/Q- Oper. Margin- RSI (14)33.79 Volatility4.93% 5.18%
OptionableYes Debt/Eq- EPS Q/Q63.90% Profit Margin- Rel Volume0.97 Prev Close4.44
ShortableYes LT Debt/Eq- EarningsMar 06 AMC Payout- Avg Volume3.02M Price4.28
Recom1.60 SMA20-6.26% SMA50-16.93% SMA200-24.28% Volume2,938,452 Change-3.60%
Oct-17-22Initiated SVB Leerink Outperform $13
Sep-01-22Initiated Jefferies Buy $13
Jul-07-22Initiated Cowen Outperform $10
Aug-09-21Initiated BTIG Research Buy $7
May-06-21Initiated Stifel Buy $5.50
Jun-24-20Resumed JMP Securities Mkt Outperform $3
Mar-05-19Initiated Lake Street Buy $4
Mar-26-18Initiated Needham Buy $10
Mar-07-18Initiated JMP Securities Mkt Outperform $8
Sep-12-17Initiated Jefferies Buy $7.50
Show Previous Ratings
Mar-24-23 07:14AM
Incyte (INCY) Gets CRL for Jakafi Extended-Release Tablets
Zacks
Mar-20-23 08:33PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Mar-08-23 07:00AM
CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript
Insider Monkey
Mar-06-23 04:35PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire -10.22%
07:35AM
CTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates
Zacks
06:25AM Loading…
06:25AM
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
PR Newswire
Mar-01-23 04:20PM
CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference
PR Newswire
Feb-23-23 07:03AM
CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023
PR Newswire
Feb-07-23 08:28PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Feb-02-23 07:00AM
CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023
PR Newswire
Jan-24-23 07:18PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jan-05-23 07:00AM
CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR Newswire
Dec-28-22 09:40AM
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Zacks
Dec-20-22 06:35PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Dec-13-22 03:02PM
12 Best Multibagger Stocks to Buy Now
Insider Monkey
06:30PM Loading…
Dec-11-22 06:30PM
CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
PR Newswire
Nov-30-22 07:00AM
CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
PR Newswire
Nov-08-22 04:05PM
CTI BioPharma to Present at Upcoming November Conferences
PR Newswire +16.90%
Nov-07-22 06:05PM
CTI BioPharma (CTIC) Reports Q3 Loss, Tops Revenue Estimates
Zacks -6.93%
04:05PM
CTI BioPharma Reports Third Quarter 2022 Financial Results
PR Newswire
Nov-03-22 09:00AM
CTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
PR Newswire
Oct-27-22 04:05PM
CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022
PR Newswire
Oct-17-22 06:55PM
Why CTI BioPharma Stock Crushed the Market Today
Motley Fool
04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
01:59PM
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
Benzinga
Oct-12-22 05:47PM
Why CTI BioPharma Stock Withered on Wednesday
Motley Fool -9.06%
Sep-21-22 09:09PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
06:00PM
CTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting
PR Newswire
Aug-22-22 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Aug-09-22 06:23PM
Why CTI BioPharma Stock Got Rocked on Tuesday
Motley Fool -11.76%
06:55PM Loading…
Aug-08-22 06:55PM
CTI BioPharma (CTIC) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:05PM
CTI BioPharma Reports Second Quarter 2022 Financial Results
PR Newswire
Aug-01-22 08:37AM
CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022
PR Newswire +6.27%
Jul-21-22 05:25PM
Top Biotech Stocks for Q3 2022
Investopedia -7.96%
Jul-07-22 06:21PM
Why CTI BioPharma Stock Blasted 18% Higher Today
Motley Fool +18.33%
Jun-14-22 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire +5.23%
Jun-10-22 07:00AM
CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress
PR Newswire
Jun-03-22 08:00AM
Celularity Appoints Industry Leader Diane Parks to its Board of Directors
GlobeNewswire -5.43%
Jun-02-22 04:05PM
CTI BioPharma to Present at Upcoming June Conferences
PR Newswire
May-27-22 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
May-26-22 05:00PM
CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting
PR Newswire
May-13-22 12:19PM
Why CTI Biopharma Stock Is Surging Today
Motley Fool +14.75%
May-12-22 05:45PM
CTI BioPharma (CTIC) Reports Q1 Loss, Tops Revenue Estimates
Zacks
04:05PM
CTI BioPharma Reports First Quarter 2022 Financial Results
PR Newswire
May-10-22 07:00AM
CTI BioPharma Announces Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
PR Newswire
May-05-22 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire -5.96%
Apr-28-22 04:05PM
CTI BioPharma to Report First Quarter 2022 Financial Results on May 12, 2022
PR Newswire -7.18%
Apr-14-22 07:00AM
NCCN Guidelines® Recommend VONJO (pacritinib) for the Treatment of Myeloproliferative Neoplasms
PR Newswire
Apr-06-22 04:05PM
CTI BioPharma to Present at the 21st Annual Needham Virtual Healthcare Conference
PR Newswire
Mar-31-22 05:15PM
CTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates
Zacks -6.79%
04:01PM
CTI BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results
PR Newswire
Mar-16-22 10:00AM
Should You Buy CTI BioPharma (CTIC) After Golden Cross?
Zacks
Mar-02-22 04:05PM
CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference
PR Newswire +8.71%
Feb-28-22 08:02PM
UPDATE 2-FDA approves CTI BioPharma's bone marrow cancer drug
Reuters -19.83%
07:18PM
CTI BioPharma Announces FDA Accelerated Approval of VONJO (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
PR Newswire
Feb-18-22 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jan-06-22 04:30PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Dec-13-21 09:00AM
CTI BioPharma Presents Data from Pacritinib Program at the 63rd American Society of Hematology Meeting
PR Newswire +5.82%
Dec-11-21 11:59AM
Timothy P. Lynchs Stonepine Capital Portfolio: Top 10 Healthcare Stocks
Insider Monkey
Dec-03-21 07:24AM
The Zacks Analyst Blog Highlights: Vertex Pharma, Amgen, Blueprint Medicines, Deciphera Pharma and CTI BioPharma
Zacks +11.81%
Dec-02-21 04:30PM
CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6
PR Newswire -12.20%
10:28AM
Biotech Stock Roundup: VRTX, AMGN's Pipeline Updates, BPMC's Acquisition & More
Zacks
Dec-01-21 01:41PM
Why CTI BioPharma Stock Is Plunging Today
Motley Fool -27.11%
Nov-30-21 05:30PM
CTI BioPharma Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe Thrombocytopenia
PR Newswire -15.41%
Nov-29-21 07:00AM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire +7.26%
Nov-26-21 08:53AM
Implied Volatility Surging for CTI BioPharma (CTIC) Stock Options
Zacks +5.98%
Nov-09-21 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Nov-04-21 09:01AM
CTI BioPharma Announces Presentations at the 63rd American Society of Hematology Meeting
PR Newswire
Oct-14-21 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
06:57AM
10 Pharmaceutical Stocks to Buy According to Timothy Lynchs Stonepine Capital
Insider Monkey
Oct-05-21 10:05AM
CTI BioPharma (CTIC) Dips on Top-Line Data from COVID-19 Study
Zacks
Oct-04-21 12:22PM
CTI BioPharma's COVID-19 Candidate Misses Primary Endpoint Mark In Phase 2 Trial
Benzinga
Oct-01-21 04:05PM
CTI BioPharma Announces Topline Data from Final Analysis of the PRE-VENT Clinical Trial Evaluating Pacritinib as a Treatment for Severe COVID-19
PR Newswire
Sep-28-21 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Sep-17-21 04:05PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Sep-08-21 09:10PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Aug-26-21 04:52PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Aug-25-21 07:30AM
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
CNW Group
07:00AM
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
PR Newswire
Aug-24-21 07:00AM
CTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors
PR Newswire
Aug-07-21 10:30PM
CTI BioPharma (CTIC) Q2 2021 Earnings Call Transcript
Motley Fool
Aug-05-21 04:05PM
CTI BioPharma Reports Second Quarter 2021 Financial Results
PR Newswire
Jul-29-21 07:00AM
CTI BioPharma to Report Second Quarter 2021 Financial Results on August 5, 2021
PR Newswire
Jul-26-21 04:30PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jul-09-21 12:48AM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jun-23-21 04:30PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jun-09-21 06:45PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire +5.39%
07:00AM
CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16
PR Newswire
Jun-02-21 12:00AM
CTI BioPharma (CTIC) Q1 2021 Earnings Call Transcript
Motley Fool
Jun-01-21 04:05PM
CTI BioPharma Reports First Quarter 2021 Financial Results
PR Newswire
09:33AM
CTI BioPharma Shares Shoot Higher as FDA Accepts Pacritinib Review Application In Bone Marrow Cancer
Benzinga
07:00AM
CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis
PR Newswire
May-26-21 04:30PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
May-14-21 10:25AM
7 Reddit Penny Stocks Promising to Cure Cancer
InvestorPlace
May-12-21 08:34PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
May-05-21 07:00AM
CTI BioPharma to Report First Quarter 2021 Financial Results on June 1, 2021
PR Newswire
Apr-21-21 11:28PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire +5.86%
Apr-07-21 07:00AM
CTI BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, Apr. 14
PR Newswire
Apr-02-21 03:54PM
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Mar-31-21 11:50PM
CTI BioPharma Corp. Announces Pricing of its Public Offering of Common Stock and Preferred Stock
PR Newswire +8.58%
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fong James KEVP & Chief Commercial OfficerJan 24Option Exercise0.95100,00094,890103,565Jan 26 04:49 PM
Craig Adam RPresident and CEOJan 24Option Exercise0.8485,31771,760112,640Jan 26 05:17 PM
Fong James KEVP & Chief Commercial OfficerJan 24Sale6.00100,000600,0003,565Jan 26 04:49 PM
Craig Adam RPresident and CEOJan 24Sale6.0085,317511,92329,440Jan 26 05:17 PM
Craig Adam RPresident and CEOJan 03Option Exercise0.8484,68371,227114,123Jan 03 07:47 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJan 03Option Exercise0.9527,02125,64044,148Jan 03 06:36 PM
Craig Adam RPresident and CEOJan 03Sale6.0184,683509,22429,440Jan 03 07:47 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJan 03Sale6.0127,021162,42317,127Jan 03 06:36 PM
Craig Adam RPresident and CEODec 30Option Exercise0.8417,10014,38341,440Jan 03 07:47 PM
KIRSKE DAVIDEVP, Chief Financial OfficerDec 30Option Exercise0.9513,84713,13929,127Jan 03 06:36 PM
Craig Adam RPresident and CEODec 30Sale6.0017,100102,64829,440Jan 03 07:47 PM
KIRSKE DAVIDEVP, Chief Financial OfficerDec 30Sale6.0013,84783,09617,127Jan 03 06:36 PM
KIRSKE DAVIDEVP, Chief Financial OfficerDec 29Option Exercise0.9513,17412,50130,087Jan 03 06:36 PM
Craig Adam RPresident and CEODec 29Option Exercise0.8413,80011,60741,661Jan 03 07:47 PM
Craig Adam RPresident and CEODec 29Sale6.0013,80082,80027,861Jan 03 07:47 PM
KIRSKE DAVIDEVP, Chief Financial OfficerDec 29Sale6.0013,17479,04416,913Jan 03 06:36 PM
Craig Adam RPresident and CEONov 10Option Exercise0.84188,304158,382216,165Nov 14 04:42 PM
Craig Adam RPresident and CEONov 10Sale6.00188,3041,130,70327,861Nov 14 04:42 PM
Craig Adam RPresident and CEONov 09Option Exercise0.8453,99645,41681,857Nov 14 04:42 PM
Craig Adam RPresident and CEONov 09Sale6.0053,996324,05627,861Nov 14 04:42 PM
Metzger Michael ADirectorNov 08Option Exercise0.9591,50086,97191,500Nov 10 04:54 PM
Metzger Michael ADirectorNov 08Sale5.5891,500511,0190Nov 10 04:54 PM
KIRSKE DAVIDEVP, Chief Financial OfficerOct 04Option Exercise0.952,1092,00118,313Oct 06 04:20 PM
KIRSKE DAVIDEVP, Chief Financial OfficerOct 04Sale6.262,10913,19416,913Oct 06 04:20 PM
KIRSKE DAVIDEVP, Chief Financial OfficerOct 03Option Exercise0.9530028517,213Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerOct 03Sale6.253001,87516,913Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 30Option Exercise0.95139,841132,695156,754Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 30Sale6.05139,841845,54916,913Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 29Option Exercise0.9590085417,713Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 29Sale6.009005,40116,913Oct 03 06:26 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 16Option Exercise0.9522,59221,43839,505Sep 20 04:59 PM
KIRSKE DAVIDEVP, Chief Financial OfficerSep 16Sale6.0222,592136,00416,913Sep 20 04:59 PM
Craig Adam RPresident and CEOSep 12Option Exercise0.84242,300203,799270,161Sep 14 04:35 PM
Craig Adam RPresident and CEOSep 12Sale6.43242,3001,557,98927,861Sep 14 04:35 PM
Craig Adam RPresident and CEOAug 16Buy5.505,00027,50027,861Aug 16 04:07 PM
BVF PARTNERS L P/ILDirectorAug 09Sale6.127,210,56644,128,66419,839Aug 11 05:52 PM
BVF PARTNERS L P/ILDirectorAug 09Sale6.121,289,4347,891,3366,148Aug 11 05:52 PM
Metzger Michael ADirectorJul 07Sale6.5120,121130,9950Jul 11 04:51 PM
Craig Adam RPresident and CEOJul 06Option Exercise0.8418,22315,32741,084Jul 06 05:19 PM
Craig Adam RPresident and CEOJul 06Sale6.1118,223111,34322,861Jul 06 05:19 PM
Metzger Michael ADirectorJul 05Option Exercise0.8491,50076,961111,621Jul 07 05:02 PM
Craig Adam RPresident and CEOJul 05Option Exercise0.8427,00022,71049,861Jul 06 05:19 PM
Metzger Michael ADirectorJul 05Sale6.0891,500556,06720,121Jul 07 05:02 PM
Craig Adam RPresident and CEOJul 05Sale6.0027,000162,00022,861Jul 06 05:19 PM
Craig Adam RPresident and CEOJul 01Option Exercise0.8427,00022,71049,861Jul 06 05:19 PM
Craig Adam RPresident and CEOJul 01Sale6.0027,000162,00022,861Jul 06 05:19 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJun 17Option Exercise2.9260,000175,00057,397Jun 17 04:57 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJun 17Sale6.2160,000372,5057,397Jun 17 04:57 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJun 14Option Exercise0.9510,0009,48917,397Jun 16 04:19 PM
KIRSKE DAVIDEVP, Chief Financial OfficerJun 14Sale5.5010,00055,0007,397Jun 16 04:19 PM
Craig Adam RPresident and CEOJun 03Option Exercise0.8418,22315,32734,901Jun 03 06:16 PM
Craig Adam RPresident and CEOJun 03Sale6.0118,223109,52016,678Jun 03 06:16 PM
Craig Adam RPresident and CEOJun 02Option Exercise0.8427,00022,71043,678Jun 03 06:16 PM
Craig Adam RPresident and CEOJun 02Sale6.0027,000162,00016,678Jun 03 06:16 PM
Craig Adam RPresident and CEOJun 01Option Exercise0.8427,00022,71043,678Jun 03 06:16 PM
Craig Adam RPresident and CEOJun 01Sale6.0027,000162,00016,678Jun 03 06:16 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.